Bioline Rx reported $19.53M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Arca Biopharma USD 469M 17.79M Dec/2025
Bio Path USD -8M 846K Sep/2025
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 305.79M 221.92M Dec/2025